Back to Search Start Over

Adagene Highlights Full Year 2023 Financial Results, Provides Corporate Update

Source :
Entertainment Close-up. April 9, 2024
Publication Year :
2024

Abstract

Adagene, a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today reported financial results for the full year 2023 and provided corporate updates. 'The SAFEbody [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Entertainment Close-up
Publication Type :
Periodical
Accession number :
edsgcl.789468754